Literature DB >> 16357736

Fibromyalgia frequency in hepatitis B carriers.

Burhan Adak1, Ibrahim Tekeoğlu, Levent Ediz, Mustafa Budancamanak, Turan Yazgan, Kasim Karahocagil, Adnan Demirel.   

Abstract

BACKGROUND: Fibromyalgia (FM) is characterized by diffuse musculoskeletal pain, fatigue, morning stiffness, and sleep disturbance. Chronic viral infections may trigger FM symptoms.
OBJECTIVES: In this study, we aimed to evaluate whether there was an association between HBsAg seropositivity and fibromyalgia syndrome.
METHODS: Fifty hepatitis B carriers (HBsAg positivity and anti-HBs negativity in sera for at least 6 months) and 50 age- and sex-matched HbsAg-negative control subjects were enrolled in this study. The hepatitis B carriers with normal or slightly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were recruited from the infectious diseases outpatient clinic and the control group was recruited from the physical medicine and rehabilitation outpatient clinic. The relationship between groups was calculated by independent Student t test, chi-squared test, and Fisher exact test for comparing proportions. Alpha criterion for significance was set at P < 0.05.
RESULTS: There was no statistically significant difference between the groups according to sex, mean age, body mass index, serum ALT, and AST levels (P > 0.05). FM syndrome and FM-associated symptoms were much more prevalent in the hepatitis B group (P < 0.001).
CONCLUSION: The present study suggests that chronic hepatitis B carriage appears to increase the risk of FM and many of the typically associated symptoms. Whether this association is related to altered liver function, viral infection, concerns associated with chronic disease, or other factors, physicians should be aware of this apparent association.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357736     DOI: 10.1097/01.rhu.0000165291.91623.5c

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  7 in total

1.  The prevalence of fibromyalgia among patients with hepatitis B virus infection.

Authors:  Mustafa Ozsahin; Ibak Gonen; Fatih Ermis; Murat Oktay; Fahri Halit Besir; Ali Kutlucan; Ahmet Sahin; Safinaz Ataoglu
Journal:  Int J Clin Exp Med       Date:  2013-09-25

2.  Helicobacter pylori seropositivity in fibromyalgia syndrome.

Authors:  Nuray Akkaya; Semih Akkaya; Yusuf Polat; Meral Turk; Tufan Turk; Elif Turhal; Fusun Sahin
Journal:  Clin Rheumatol       Date:  2010-12-01       Impact factor: 2.980

3.  Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver.

Authors:  Ali Aydeniz; M Namiduru; I Karaoglan; O Altindag; E Yagiz; S Gursoy
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

4.  Association between fibromyalgia and coronary heart disease and coronary catheterization.

Authors:  Jacob N Ablin; Natella Beilinson; Valerie Aloush; Ori Elkayam; Ariel Finkelstein
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

5.  Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).

Authors:  Nancy Agmon-Levin; Yaron Zafrir; Shaye Kivity; Ari Balofsky; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

6.  COVID-19 associated hospitalization in 571 patients with fibromyalgia-A population-based study.

Authors:  Mor Amital; Niv Ben-Shabat; Howard Amital; Dan Buskila; Arnon D Cohen; Daniela Amital
Journal:  PLoS One       Date:  2021-12-30       Impact factor: 3.240

7.  Seroprevalence of parvovirus B19 in fibromyalgia syndrome.

Authors:  Mehves Buyukkose; Erkan Kozanoglu; Sibel Basaran; Ozlem Bayramoglu; Fugen Yarkin
Journal:  Clin Rheumatol       Date:  2008-12-05       Impact factor: 3.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.